Mutations within the Plasmodium falciparum dihydrofolate reductase gene (Pfdhfr) contribute to resistance to antimalarials such as sulfadoxine-pyrimethamine (SP). Of particular importance are the single nucleotide polymorphisms (SNPs) within codons 51, 59, 108, and 164 in the Pfdhfr gene that are associated with SP treatment failure. Given that traditional genotyping methods are time-consuming and laborious, we developed an assay that provides the rapid, high-throughput analysis of parasite DNA isolated from clinical samples. This assay is based on asymmetric real-time PCR and melt-curve analysis (MCA) performed on the LightCycler platform. Unlabeled probes specific to each SNP are included in the reaction mixture and hybridize differentially to the mutant and wild-type sequences within the amplicon, generating distinct melting curves. Since the probe is present throughout PCR and MCA, the assay proceeds seamlessly with no further addition of reagents. This assay was validated for analytical sensitivity and specificity using plasmids, purified genomic DNA from reference strains, and parasite cultures. For all four SNPs, correct genotypes were identified with 100 copies of the template. The performance of the assay was evaluated with a blind panel of clinical isolates from travelers with low-level parasitemia. The concordance between our assay and DNA sequencing ranged from 84 to 100% depending on the SNP. We also directly compared our MCA assay to a published TaqMan real-time PCR assay and identified major issues with the specificity of the TaqMan probes. Our assay provides a number of technical improvements that facilitate the high-throughput screening of patient samples to identify SP-resistant malaria.
Sulfadoxine-pyrimethamine (SP) is widely used throughout sub-Saharan Africa for the treatment of uncomplicated Plasmodium falciparum malaria and as intermittent preventive therapy in pregnancy (10, 18) . However, the efficacy of SP has been severely compromised by the rapid emergence of resistant strains (21) . Resistance can be attributed largely to single nucleotide polymorphisms (SNPs) within the P. falciparum dhfr and dhps (Pfdhfr and Pfdhps, respectively) genes that inhibit the activity of enzymes involved in folate biosynthesis (15, 17, 23) . With resistance to pyrimethamine, specific Pfdhfr mutations (N51I, C59R, and S108N) are associated with increased levels of resistance in vitro and clinical treatment failure in vivo (5, 15) . The accumulation of mutations at codons 51, 59, and 108 confers increasing levels of resistance, with the triple mutant becoming the dominant genotype in many areas in which P. falciparum is endemic (21) . Recently, a mutation at Pfdhfr codon 164 (I164L) has emerged as a new predictor of treatment failure, and quadruple mutant genotypes have been identified in southeast Asia, South America, and Africa (10, 15) .
Methods that genetically identify SP-resistant genotypes underpin molecular surveillance efforts to monitor resistance. Many tools have been developed to genotype mutations within the dhfr gene, including techniques such as restriction fragment length polymorphism and nested PCR. Recently, the application of real-time PCR for genotyping malaria parasites has been described (19) . Studies by Alker et al. (2, 3) used realtime PCR with sequence-specific probes to detect four of the Pfdhfr SNPs conferring resistance to pyrimethamine. Despite excellent sensitivity reported for this assay, cross-reactivity between probes has been observed (13) . Other methods include fluorescence resonance energy transfer (FRET) in conjunction with melt-curve analysis (MCA); hybridization probes are used to differentiate between wild-type and mutant sequences based on thermodynamic stability (5) . However, these probes are added following the amplification step and increase the risk of nucleic acid contamination.
Recent advances in MCA have enabled the detection of SNPs by high-resolution genotyping within closed-tube systems (4, 12) . High-resolution DNA melting (HRM) analysis uses an intercalating dye that dissociates from double-stranded DNA at increased temperatures. The genotype is identified based on inherent differences in melting temperatures between wildtype and mutant DNA amplicons (4, 12) . An alternative approach uses asymmetric PCR in the presence of the DNA intercalating dye LCGreen Plus with an unlabeled probe specific to the SNP of interest (12) . During asymmetric PCR, the sense strand of the amplicon is generated in excess, allowing the probe to anneal and form a duplex; LCGreen Plus binds to the duplex, generating a fluorescent signal. During melt-curve analysis, the probe dissociates from the amplicon, resulting in a decrease in the fluorescent signal. If there is a base pair mismatch between the probe and the amplicon, the probe will dissociate from the DNA template at a lower temperature compared to that of a perfectly matched sequence. The resolution of different SNPs is achieved by analyzing the melt-curve profiles for the probe-amplicon complex. The implementation of this assay has been reported for the detection of polymorphisms and mutations associated with a number of human diseases, including diabetes and cancer (7, 8) . We applied this method to genotype four polymorphisms in the dhfr gene from clinical specimens collected from travelers and immigrants with P. falciparum malaria in Alberta, Canada. This method demonstrated superior sensitivity to probe-based real-time PCR and offers a novel molecular tool for the high-throughput genotyping of malaria.
MATERIALS AND METHODS

Plasmids.
A 641-bp region of the dhfr gene containing all four SNPs was amplified from P. falciparum 3D7 and V1/S genomic DNA (gDNA) using the following primers: 5Ј-ATGATGGAACAAGTCTGCGA-3Ј (forward) and 5Ј-A CTAGTATATACATCGCTAACAGA-3Ј (reverse). DNA amplification was performed using a 2720 Thermal Cycler (Applied Biosystems) with the following program: 95°C for 5 min, 40 cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for 45 s. The dhfr amplicons were cloned into the vector pCR 2.1-TOPO using the TopoTA cloning kit (Invitrogen). Clones were verified by sequencing. Plasmids were quantified by spectrophotometry and serially diluted from 10 6 to 10 0 copies to generate a standard curve.
Control genomic DNA and clinical samples. Genomic DNA from four strains of P. falciparum (3D7, 7G8, W2, and V1/S) was obtained from the Malaria Reagent Repository Resource (http://mr4.org). DNA was serially diluted 10-fold from 1 g/l to 0.1 pg/l to generate standards for melt-curve analysis. The laboratory strain 3D7 was cultured in human erythrocytes as described previously (22) . Parasitemia was determined from Giemsa-stained thin smears, and the number of parasites/l of blood was calculated based on the parasitemia, an estimated concentration of 5 ϫ 10 9 red blood cells/ml blood, and a hematocrit of 3%. DNA was extracted using the Precision System Science DNA Magtration system 12GC by following the DNA 200 extraction protocol (kit E2003) and was eluted into a 100-l volume (16) . Clinical samples from patients infected with P. falciparum were obtained from the Provincial Laboratory for Public Health in Edmonton, Alberta, Canada. DNA was extracted from 40 l of whole blood according to the protocol described above. This study was approved by the Health Research Ethics Board of the University of Alberta.
Real-time PCR and melt-curve analysis. Asymmetric PCR was carried out based on the methodology described previously (12) using a LightCycler 2.0 (Roche) with conditions optimized for amplification and the detection of the four SNP targets from the P. falciparum dhfr gene. Primers and unlabeled probes were synthesized by Integrated DNA Technologies, Inc. (IDT) (Coralville, IA) and are listed in Table 1 . Probes are complementary to the wild-type sequence and modified at the 3Ј end with a C3 spacer (12) . For codons 51 and 59, the total reaction volume of 20 l consisted of 2 l of DNA, 1ϫ PCR buffer (Promega), 1ϫ LC Green Plus (Idaho Technology Inc.), 50 nM forward primer, 500 nM (each) reverse primer and unlabeled probe, 200 M deoxynucleoside triphosphates (dNTPs), 4 mM MgCl 2 , 0.032% bovine serum albumin (BSA), and 1.25 U of Taq (Promega). The amplification program consisted of an initial denaturation at 95°C for 2 min, 40 cycles of 95°C for 30 s, 54°C for 10 s, and 72°C for 30 s, and then a 10-min extension at 72°C. The ramp rates for the denaturation, annealing, and extension segments of the PCR were 20, 3, and 0.1°C/s, respectively. For codons 108 and 164, the reaction conditions were similar, except the final concentration of MgCl 2 was 3.5 mM and the annealing temperature during PCR amplification was 48°C. Melt-curve analysis for all SNPs was performed as follows: 95°C for 30 s and then 55°C for 1 min with a ramp rate of 0.01°C/s, and a final denaturation at 95°C for 30 s. The software program for the LightCycler (version 4.1) was used to genotype samples according to the melt-curve profiles. Control genomic DNAs were used as external standards to genotype the panel of clinical samples. To generate mixtures of wild-type and mutant DNA, gDNAs (1 ng/l) from clinical samples of each genotype were mixed at 1:1, 1:3, and 3:1 ratios in the PCR-MCA reaction.
Pyrosequencing and direct sequencing. Pyrosequencing was used to confirm the genotype at codons 51, 59, and 108 essentially as described by Zhou et al. (24) , with modifications to the primers (Table 2 ) and conditions. Nested PCR was performed in 25-l (first round) or 100-l (second round) reaction mixtures with 1ϫ PCR buffer (Promega), 100 M dNTPs, 1.5 mM MgCl 2 , 200 nM primers, and 0.025 U/l Taq (Promega). First-round PCR steps included 95°C for 5 min; 25 cycles of 94°C for 30 s, 55°C for 30 s, and 68°C for 45 s; and 10 cycles of 94°C for 30 s, 52°C for 30 s, and 68°C for 45 s. For nested reaction mixtures, 10 l from the first round served as the template. Second-round PCR steps included 95°C for 5 min; 15 cycles of 94°C for 30 s, 55°C for 30 s, and 68°C for 45 s; 20 cycles of 94°C for 30 s, 52°C for 30 s, and 68°C for 45 s; and 10 cycles 94°C for 30 s, 50°C for 30 s, and 68°C for 45 s. Pyrosequencing reactions were carried out on a PSQ 96MA with nucleotide dispensation order 10 (GATC). For codon 164, purified PCR products (212 bp) were sequenced in both directions (Applied Genomics Centre, University of Alberta) using the amplification primers (Table 1) .
TaqMan PCR. The TaqMan-based real-time PCR method described by Alker et al. (2, 3) was performed on the ABI Prism 7000 sequence detection system using published primers (IDT) and probes (Applied Biosystems) (2, 3) .
RESULTS
Sensitivity of melt-curve analysis for genotyping Pfdhfr.
A method for high-resolution melt-curve analysis (MCA) was developed to genotype four SNPs within the Pfdhfr gene that are associated with resistance to the antimalarial pyrimethamine. For each SNP, the asymmetric amplification of the target region within Pfdhfr was optimized to generate an excess of the sense strand. As described by Montgomery et al. (12), reactions include an antisense oligonucleotide probe that recognizes the SNP of interest and binds to the excess sense DNA produced by asymmetric PCR. During MCA, the dissociation of the probe from the template occurs at a specific melting temperature and results in a reduction in fluorescence as the duplex DNA strands separate. In our study, probes were designed to complement the wild-type SNP; thus, the dissociation of the probe occurs at a lower temperature when there is a mismatch between the probe and template. Genomic DNA extracted from P. falciparum 3D7 and V1/S strains was used to develop the melting standards for the wildtype and mutant sequences, respectively. The 3D7 strain contains the wild-type sequence at each target codon: N51, C59, S108, and I164, whereas the V1/S strain contains the mutant sequences 51I, 59R, 108N, and 164L. Representative melt curves from these two strains are shown for each of the four probes (Fig. 1) . The peak that melts at higher temperatures corresponds to the full-length amplicon from the PCR, while the peak that dissociates at lower temperatures corresponds to the melting of the probe-amplicon duplex. For all four SNPs, the wild-type and mutant genotypes were clearly distinguished based on their melt-curve profiles.
Serial dilutions of plasmids containing the amplified region of the dhfr gene were used to determine the analytical sensitivity of melt-curve analysis for genotyping at each SNP. The genotyping program on the LightCycler identified the template as either wild type or mutant based on a comparison to external genomic DNA standards. Reactions were performed in triplicate to determine the reproducibility of the assay to correctly distinguish wild-type from mutant strains. For all of the SNPs, genotypes were consistently identified at 100 template copies (Table 3) . Although PCR amplification occurred at FIG. 1. Genotyping of P. falciparum SNPs by asymmetric PCR and melt-curve analysis. Wild-type and mutant gDNA was amplified in the presence of probes specific for SNPs within codons 51 (A), 59 (B), 108 (C), and 164 (D). The probe-amplicon duplex melts at a lower temperature (smaller peak), and the double-stranded amplicon melts at a higher temperature (larger peak). Probe-amplicon duplexes containing a mismatch (51I, 59R, 108N, and 164L) dissociate at a lower temperature than duplexes with the wild-type sequence (N51, C59, S108, and I164).
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on September 12, 2017 by guest http://jcm.asm.org/ lower plasmid dilutions, the shape of the melt curves was broader and genotypes were scored either as negative or unknown by the software program. A negative sample lacks sufficient DNA template to generate a melt curve, whereas an unknown sample implies that the melt curve generated does not have a shape similar to that of the standards. The sensitivity of the assay was further evaluated with genomic DNA extracted from P. falciparum strains containing either the wildtype or mutant sequences (Table 4) . Concentrations of genomic DNA were tested between 1 g/l and 0.1 pg/l. The correct identification of the genotype in triplicate reactions was achieved at template concentrations of 10 or 1 pg/l, depending on the specific SNP. Furthermore, we prepared mixtures of the gDNA from the wild-type and mutant templates to determine the sensitivity of the assay in detecting mixed infections. Both the wild-type and mutant SNPs were detected in triplicate reactions when present at equal concentrations. At positions 51 and 108, the mutant could be detected in 3/3 reactions even at a 1:3 ratio with wild-type DNA. At positions 59 and 164, the mutant SNP was detected in 2/3 replicates when present at this lower ratio.
To determine the dynamic range of the assay, the parasite strain 3D7 was grown in culture to a parasitemia of approximately 20% and serially diluted with uninfected erythrocytes.
A range of parasite concentrations from 3 ϫ 10 4 parasites/l blood to 1.5 parasites/l was tested. The 3D7 strain is wild type at all four dhfr SNPs, enabling us to determine the limit of detection for the wild-type genotype. Genomic DNA was extracted from these samples and tested by MCA (Table 5) . MCA was able to correctly identify the wild-type genotype from cultures diluted to 1,500 parasites/l for codon 59, 15 parasites/l for codons 51 and 164, and 1.5 parasites/l for codon 108.
Evaluation of MCA with clinical samples. To evaluate the performance of the assay with clinical samples, a panel of 44 blood samples was genotyped by MCA. All specimens were confirmed infections with P. falciparum as determined by realtime PCR performed in a clinical diagnostics laboratory (16) . Genotypes were identified by the LightCycler software at all four SNPs in 30 of the 44 samples. The sensitivity of the assay to genotype a given SNP was calculated based on the number of specimens tested that were assigned a genotype by the LightCycler software. For our panel of samples, the sensitivity of genotype calling for each individual SNP was the following: 93.2% at codon 51, 86.4% at codon 59, 84.1% at codon 108, and 81.8% at codon 164 (Table 6 ). To determine the accuracy of the genotype assigned by MCA, the identification of each SNP was compared to a gold standard. Pyrosequencing served as the gold standard for codons 51, 59, and 108. In 2/44 samples, the genotype could not be identified at positions 51 and 108 by pyrosequencing, and these were genotyped by direct sequencing. Direct sequencing also identified the genotype of all 44 samples at codon 164 and served as the gold standard for this SNP. No samples could be identified by MCA but not by either of the sequencing methods. Concordance between MCA and sequence-based methods for the correct identification of the genotype ranged from 84 to 100% (Table 6 ). In the 30 samples for which a genotype was called at all four SNPs by MCA, 24 (80%) had the correct genotype. Of the specimens that could not be genotyped or that were called negatives, 12/14 had a parasitemia of less than 0.1% by microscopy. This establishes the clinical sensitivity for the assay where the level of infection is below the limit of detection.
Interestingly, there were two clinical samples that displayed different melt-curve profiles compared to that of the wild-type and mutant standards at codons 51 and 108. These curves resembled a hybrid form of the mutant and wild-type curves with two clear peaks at the lower temperatures (Fig. 2) . Sequencing confirmed that these samples contained a mixture of 
a Results are reported as the number of replicates detected in triplicate reactions.
b P. falciparum 3D7 cultures at approximately 20% parasitemia.
wild-type and mutant sequences at codons 51 and 108, indicating polyclonal infections.
Comparison of MCA and TaqMan PCR for genotyping Pfdhfr. In previous publications, Alker et al. reported a method using hydrolysis probes (TaqMan technology) to discriminate between wild-type and mutant genotypes in the Pfdhfr gene (2, 3) . We compared the sensitivity and specificity of genotyping by MCA with the TaqMan methodology as described previously. We initially validated the primers and probes using our plasmids that contained either the wild-type (3D7) or mutant (V1/S) sequences at 10 6 copies of the dhfr gene. We observed poor specificity of the probes for the correct template, as was observed by others (13) . In particular, the wild-type probe for codon 59 bound indiscriminately to templates with the wildtype and mutant DNA sequences.
We assessed our panel of clinical samples using the Alker method. The sensitivity of genotype calling for the individual SNPs was the following: 84.1% at codon 51, 93.2% at codon 59, 9.1% at codon 108, and 40.9% at codon 164. Of those specimens that could be genotyped, the concordance of TaqMan real-time PCR with the sequencing methods was 97.3% at codon 51, 25.6% at codon 59, 25% at codon 108, and 94.7% at codon 164 (Table 6 ). It is important to note that given the poor specificity of the probes for codon 59, all of the specimens were 
DISCUSSION
We have developed a method for high-resolution MCA to genotype the major SNPs in the Pfdhfr gene that are associated with resistance to pyrimethamine. The analytical validation of this assay demonstrated excellent sensitivity and specificity for both wild-type and mutant genotypes. The assay was further validated with a panel of clinical samples and demonstrated good concordance with sequencing methods. It is important to recognize that our panel of clinical samples consisted primarily of samples from returning travelers with low-level parasitemic infections. By microscopy, many of these samples had a parasitemia of less than 0.1%, suggesting that the level of parasite DNA was below the limit of detection of our assay.
However, compared to those for the published TaqManbased real-time PCR assay by Alker et al. (2, 3) , our assay demonstrated greater sensitivity and specificity. Although the reported sensitivity of the TaqMan assay is 10 copies of the target DNA (2), this was not observed in our experiments or by another laboratory that attempted to reproduce this method (1, 2, 13) . Of significant concern, the poor specificity of the probes for codon 59 resulted in all of our panel samples being genotyped as wild type when in fact 74% were confirmed to be mutant by pyrosequencing. The cross-reactivity between the wild-type and mutant probes in the TaqMan assay precluded us from obtaining meaningful results for this SNP. This is especially problematic as the 51, 59, and 108 SNPs are the most commonly reported in many areas in Africa (20) . Furthermore, the Alker method requires that the investigator categorize the sample based on the cycle threshold (C T ) values. This procedure can introduce bias and the misinterpretation of results when competition occurs between probes. In contrast, MCA uses a relatively simple approach to genotyping, achieving high-resolution and -throughput capacity. The design of the assay facilitates its application to monitor mutations associated with other resistance genes. Resistance to cycloguanil, a metabolite of the antimalarial proguanil, is associated with many of the same mutations in the Pfdhfr gene (14) , enabling the surveillance of resistance to this drug with the primers and probes described here. It is especially important to adapt this assay to genotype the mutations within the Pfdhps gene (436, 437, 540, 581, and 613) that are associated with resistance to sulfadoxine.
Genotyping Pfdhfr SNPs by MCA has been described elsewhere using fluorescence resonance energy transfer (FRET) methods (6, 11) , but this assay requires an open system, as well as the use of labeled probes, in contrast to our method, which uses less costly, unlabeled probes in a closed system. Another advantage of our assay is the ability to detect mixed infections. In countries in which malaria is highly endemic, people are likely to be infected with more than one strain of P. falciparum (17) . Minor strains of polyclonal infections can be readily identified with this assay as two distinct probe-amplicon peaks. In our study, we identified two infections that contained both a wild-type and mutant SNP at codons 51 and 108.
A similar assay for genotyping resistant P. falciparum has been developed using HRM with an intercalating dye analogous to LCGreen Plus. The HRM method uses the dissociation profile for each SNP to distinguish between wild-type and mutant sequences. However, the HRM analysis described by Andriantsoanirina et al. (4) does not use probes and has limited ability to resolve individual mutations that are located within close proximity on the DNA, such as the SNPs in codons 51 and 59. HRM is best suited to genotype a single SNP per amplicon (9) . Sequencing is another method that is widely used for genotyping and served as the gold standard for our study. However, one of the key limitations for high-throughput genotyping with sequencing-based methods is the time required for processing samples. Typically it takes 2 days to set up the PCR, perform the DNA purification procedures and quantitation, run the sequencing reaction, and perform the data analysis. The need for PCR amplification prior to sequencing also risks contamination by amplicons. In contrast, the MCA assay can be set up, run, and analyzed within 4 h, and it is contained within a closed-tube system.
MCA will be a useful tool for the molecular surveillance of resistant genotypes within endemic populations with higherlevel parasitemic infections. It can be implemented to monitor the efficacy of antimalarial drugs and, in particular, the emergence of drug-resistant strains in pregnant women undergoing intermittent preventive therapy. This high-throughput assay enables the rapid screening of large numbers of samples and provides a new tool to support efforts for malaria surveillance and elimination. Resistance data can be shared with the recently established World Antimalarial Resistance Network (WARN) to contribute to global efforts in malaria surveillance. One of the core components of this surveillance program is monitoring molecular markers associated with drug resistance. Given the increase in travel to countries in which malaria is endemic, laboratories in nonendemic countries can play an active role in these surveillance efforts by screening P. falciparum strains from returning travelers. Once applied to a broader selection of resistance genes, the technique presented here can be useful to identify global changes in resistance patterns for malaria.
